Hap Trading, LLC Crispr Therapeutics Ag Call Options Transaction History

Hap Trading, LLC

$872 Billion
Q3 2024

Call Options

19 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 May 13, 2024	BUY	$60.67 - $89.12 $1.24 Million - $1.82 Million	20,400 New	20,400 $1.53 Million
Q2 2023 Aug 11, 2023	BUY	$43.47 - $67.77 $1.77 Million - $2.76 Million	40,700 New	40,700 $2.28 Million
Q4 2022 Feb 14, 2023	SELL	$39.19 - $65.67 $58,785 - $98,505	-1,500 Reduced 6.91%	20,200 $3,000
Q3 2022 Nov 14, 2022	BUY	$61.1 - $83.78 $42,770 - $58,646	700 Added 3.33%	21,700 $42,000
Q2 2022 Aug 12, 2022	BUY	$43.23 - $73.83 $103,751 - $177,192	2,400 Added 12.9%	21,000 $48,000
Q1 2022 May 12, 2022	SELL	$53.19 - $79.24 $494,667 - $736,932	-9,300 Reduced 33.33%	18,600 $47,000
Q4 2021 Feb 14, 2022	BUY	$70.09 - $111.29 $399,513 - $634,353	5,700 Added 25.68%	27,900 $77,000
Q3 2021 Nov 10, 2021	SELL	$110.2 - $156.64 $242,440 - $344,607	-2,200 Reduced 9.02%	22,200 $159,000
Q2 2021 Aug 11, 2021	SELL	$100.84 - $161.89 $6.22 Million - $9.99 Million	-61,700 Reduced 71.66%	24,400 $620,000
Q1 2021 May 14, 2021	BUY	$110.72 - $210.04 $6.34 Million - $12 Million	57,300 Added 198.96%	86,100 $322,000
Q4 2020 Feb 16, 2021	BUY	$79.67 - $173.23 $979,941 - $2.13 Million	12,300 Added 74.55%	28,800 $1.46 Million
Q3 2020 Nov 13, 2020	BUY	$78.5 - $100.64 $431,750 - $553,520	5,500 Added 50.0%	16,500 $425,000
Q2 2020 Aug 10, 2020	SELL	$38.5 - $76.05 $265,650 - $524,745	-6,900 Reduced 38.55%	11,000 $330,000
Q1 2020 May 08, 2020	SELL	$33.68 - $62.53 $235,760 - $437,710	-7,000 Reduced 28.11%	17,900 $133,000
Q4 2019 Feb 11, 2020	BUY	$36.68 - $73.13 $436,492 - $870,247	11,900 Added 91.54%	24,900 $354,000
Q3 2019 Nov 12, 2019	SELL	$40.99 - $52.56 $90,178 - $115,632	-2,200 Reduced 14.47%	13,000 $131,000
Q2 2019 Aug 14, 2019	SELL	$35.45 - $48.2 $365,135 - $496,460	-10,300 Reduced 40.39%	15,200 $103,000
Q1 2019 May 10, 2019	BUY	$28.02 - $40.87 $274,596 - $400,526	9,800 Added 62.42%	25,500 $57,000
Q4 2018 Feb 12, 2019	BUY	$22.73 - $42.34 $356,861 - $664,738	15,700 New	15,700 $19,000

Others Institutions Holding CRSP

# of Institutions

491

Shares Held

58M

Call Options Held

1.1M

Put Options Held

1.9M

Capital International Investors Los Angeles, CA

7.93M
Shares

$367 Million
0.07% of portfolio
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl

7.5M
Shares

$347 Million
3.35% of portfolio
State Street Corp Boston, MA

2.99M
Shares

$139 Million
0.01% of portfolio
Sumitomo Mitsui Trust Holdings, Inc.

2.97M
Shares

$137 Million
0.1% of portfolio
Nikko Asset Management Americas, Inc.

2.97M
Shares

$137 Million
1.61% of portfolio

View Full List

About CRISPR Therapeutics AG

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $3.61B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

More about CRSP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hap Trading, LLC with notifications on news.

Account